triamterene and hydrochlorothiazide
Generic: triamterene and hydrochlorothiazide
Labeler: bluepoint laboratoriesDrug Facts
Product Profile
Brand Name
triamterene and hydrochlorothiazide
Generic Name
triamterene and hydrochlorothiazide
Labeler
bluepoint laboratories
Dosage Form
TABLET
Routes
Active Ingredients
hydrochlorothiazide 25 mg/1, triamterene 37.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68001-387
Product ID
68001-387_14ca7c10-0f45-bfdf-e063-6294a90ad956
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA073449
Listing Expiration
2026-12-31
Marketing Start
2019-06-18
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68001387
Hyphenated Format
68001-387
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
triamterene and hydrochlorothiazide (source: ndc)
Generic Name
triamterene and hydrochlorothiazide (source: ndc)
Application Number
ANDA073449 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/1
- 37.5 mg/1
Packaging
- 500 TABLET in 1 BOTTLE, PLASTIC (68001-387-03)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "14ca7c10-0f45-bfdf-e063-6294a90ad956", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000008859", "N0000175418"], "upc": ["0368001387002", "0368001388009"], "unii": ["0J48LPH2TH", "WS821Z52LQ"], "rxcui": ["310812", "310818"], "spl_set_id": ["b8a55c23-b509-4790-88fa-9dc9bacd4bbe"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]", "Decreased Renal K+ Excretion [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Potassium-sparing Diuretic [EPC]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE, PLASTIC (68001-387-03)", "package_ndc": "68001-387-03", "marketing_start_date": "20190618"}], "brand_name": "Triamterene and Hydrochlorothiazide", "product_id": "68001-387_14ca7c10-0f45-bfdf-e063-6294a90ad956", "dosage_form": "TABLET", "pharm_class": ["Decreased Renal K+ Excretion [PE]", "Increased Diuresis [PE]", "Increased Diuresis [PE]", "Potassium-sparing Diuretic [EPC]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "68001-387", "generic_name": "Triamterene and Hydrochlorothiazide", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triamterene and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "TRIAMTERENE", "strength": "37.5 mg/1"}], "application_number": "ANDA073449", "marketing_category": "ANDA", "marketing_start_date": "20190618", "listing_expiration_date": "20261231"}